Academic and Non-Profit Partnering Terms and Agreements 2021-2026

$4,995.00

Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. 

Publication date
March 2026
Number of pages
1300+
Product type
Research report
Report edition
6
SKU
CP1011

Benchmark Academic Collaboration Strategies Across the Global Life Sciences Industry

Free report sample

The Global Academic and Non-Profit Partnering Terms and Agreements 2021-2026 report provides a comprehensive analysis of partnerships between pharmaceutical and biotechnology companies and academic or non-profit research institutions. Designed for business development, licensing, and research strategy professionals, the report delivers detailed insight into how companies structure collaborations with universities, research institutes, and non-profit organizations to accelerate innovation and advance new therapies.

Fully revised and updated, the report analyzes thousands of academic and non-profit partnership agreements announced since 2021, providing an extensive view of how life sciences companies collaborate with research institutions across discovery, development, and commercialization activities.

Each deal record includes financial information where available and links to detailed online deal records. Where agreements have been publicly filed, the report also provides access to the underlying contract documents submitted to regulators, allowing users to review the detailed terms negotiated between partners.

By combining comprehensive deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating academic collaboration opportunities, structuring research partnerships, and negotiating more effective agreements.


Key Benefits

Save Significant Research Time
Access a consolidated resource covering thousands of academic and non-profit partnering agreements instead of searching multiple databases, press releases, and regulatory filings.

Benchmark Academic Collaboration Deal Structures
Understand how pharmaceutical and biotechnology companies structure partnerships with universities and non-profit institutions, including research collaborations, licensing arrangements, and development partnerships.

Analyze Financial Terms with Confidence
Review available financial data—including headline deal values, upfront payments, milestone payments, and royalty structures—to benchmark the financial value of comparable partnerships.

Access Real Contract Documents
Where available, explore actual academic collaboration agreements filed with regulators, providing insight into contractual provisions that are rarely disclosed publicly.

Identify the Most Active Academic Dealmakers
Discover which pharmaceutical companies, research institutions, and non-profit organizations are most active in forming academic partnerships.

Track Industry Collaboration Trends
Analyze academic partnering activity since 2019 across technologies, therapeutic areas, and development stages.


What’s Included in the Report

  • Analysis of academic and non-profit partnering trends since 2021

  • Overview of academic collaboration structures and financial models

  • Review of leading academic partnerships by deal value

  • Profiles of the most active academic and non-profit dealmakers

  • Detailed analysis of deals organized by company, development stage, technology type, and therapy area

  • A comprehensive directory of academic partnering agreements

  • Links to online deal records and contract documents where available

Deals are indexed across multiple categories—including company A–Z, deal value, development stage, technology type, and therapy target—allowing users to quickly identify comparable transactions.


Due Diligence Insights from Real Agreements

By reviewing actual academic collaboration contracts, the report enables users to evaluate key partnership provisions such as:

  • Rights granted or licensed under the collaboration

  • Financial payment structures and milestone triggers

  • Intellectual property ownership and licensing scope

  • Research, development, and commercialization responsibilities

  • Exclusivity provisions and territorial rights

  • Contract duration, termination clauses, and governance structures

Access to real agreements provides insight into the detailed terms negotiated between companies and research institutions—information rarely disclosed in press releases or standard deal databases.


Why This Report Matters

Partnerships with universities and non-profit research institutions play a critical role in early-stage innovation across the life sciences industry. These collaborations enable companies to access breakthrough research, share development risk, and accelerate the translation of scientific discoveries into commercial therapies.

By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to evaluate academic partnership opportunities, structure stronger research collaborations, and negotiate more effectively.

Key Benefits

Save Significant Research Time
Access a consolidated resource covering thousands of academic and non-profit partnering agreements instead of searching multiple databases, press releases, and regulatory filings.

Benchmark Academic Collaboration Deal Structures
Understand how pharmaceutical and biotechnology companies structure partnerships with universities and non-profit institutions, including research collaborations, licensing arrangements, and development partnerships.

Analyze Financial Terms with Confidence
Review available financial data—including headline deal values, upfront payments, milestone payments, and royalty structures—to benchmark the financial value of comparable partnerships.

Access Real Contract Documents
Where available, explore actual academic collaboration agreements filed with regulators, providing insight into contractual provisions that are rarely disclosed publicly.

Identify the Most Active Academic Dealmakers
Discover which pharmaceutical companies, research institutions, and non-profit organizations are most active in forming academic partnerships.

Track Industry Collaboration Trends
Analyze academic partnering activity since 2019 across technologies, therapeutic areas, and development stages.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Academic and Non-Profit dealmaking

 

2.1. Introduction

2.2. Academic and Non-Profit partnering over the years

2.3. Most active Academic and Non-Profit dealmakers

2.4. Academic and Non-Profit partnering by deal type

2.5. Academic and Non-Profit partnering by therapy area

2.6. Academic and Non-Profit partnering by technology type

2.7. Deal terms for Academic and Non-Profit partnering

2.7.1 Academic and Non-Profit partnering headline values

2.7.2 Academic and Non-Profit deal upfront payments

2.7.3 Academic and Non-Profit deal milestone payments

2.7.4 Academic and Non-Profit royalty rates

 

Chapter 3 – Leading Academic and Non-Profit deals

 

3.1. Introduction

3.2. Top Academic and Non-Profit deals by value

 

Chapter 4 – Most active Academic and Non-Profit dealmakers

 

4.1. Introduction

4.2. Most active Academic and Non-Profit dealmakers

4.3. Most active Academic and Non-Profit partnering company profiles

 

Chapter 5 – Academic and Non-Profit contracts dealmaking directory

 

5.1. Introduction

5.2. Academic and Non-Profit contracts dealmaking directory

 

Chapter 6 – Academic and Non-Profit dealmaking by technology type

 

Appendices

 

Appendix 1 – Academic and Non-Profit deals by company A-Z

Appendix 2 – Academic and Non-Profit deals by stage of development

Appendix 3 – Academic and Non-Profit deals by deal type

Appendix 4 – Academic and Non-Profit deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Academic and Non-Profit partnering since 2021

Figure 2: Active Academic and Non-Profit dealmaking activity since 2021

Figure 3: Academic and Non-Profit partnering by deal type since 2021

Figure 4: Academic and Non-Profit partnering by disease type since 2021

Figure 5: Academic and Non-Profit partnering by technology type since 2021

Figure 6: Academic and Non-Profit deals with a headline value

Figure 7: Academic and Non-Profit deals with an upfront value

Figure 8: Academic and Non-Profit deals with a milestone value

Figure 9: Academic and Non-Profit deals with a royalty rate value

Figure 10: Top Academic and Non-Profit deals by value since 2021

Figure 11: Most active Academic and Non-Profit dealmakers since 2021

Pricing options

 

  • $4,995: single-user
  • $6,995: multi-user
  • $8,995: corporate/enterprise license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

4D Molecular Therapeutics, 4D Path, 4D Pharma, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 10X Genomics, 180 Life Sciences, 221b Foundation, 908 Devices, A*STAR Agency for Science, Technology and Research, A*STAR Bioprocessing Technology Institute, A*STAR’ Institute of Molecular and Cell Biology, Aachen University, AA Medical, Aarhus University, Aarhus University Hospital, Abbott Laboratories, Abbvie, Abceutics, Abera Bioscience, AbFero Pharmaceuticals, Abintus Bio, ABL Europe, ABLi Therapeutics, Abramson Cancer Center, AbTherx, ABT Innovations, Abu Dhabi Stem Cells Center, ABVC BioPharma, ABX, Accelerator for Technological Research in Genomic Therapies, AccuLine, Accumulus Synergy, AccuStem Sciences, Acer Therapeutics, Ache, Achilles Therapeutics, Acibadem University, Aclipse Therapeutics, Acrobat Genomics, Actelion, Actinium Pharmaceuticals, Actuate Therapeutics, AcureX Therapeutics, Acurx Pharmaceuticals, Adagene, Adamis Pharmaceuticals, Adaptive Phage Therapeutics, Addex Therapeutics, Addgene, Adhera Therapeutics, Adimune, Adnab, Adolore Biotherapeutics, Advanced Development of Additive Manufacturing, Advancium Health Network, Aegis Life, Aerogen, Aethon Therapeutics, Affini-T Therapeutics, Affinia Therapeutics, AFYX Therapeutics, AGC Biologics, Agena Bioscience, Agencja Badan Medycznych, Agendia, AgeX Therapeutics, Agilent Technologies, AgonOx, AgroSource, AHN Autoimmunity Institute, AIBody, Aidoc, AIkido Pharma, Aileron Therapeutics, AI Longevity, AI Medical Service, AIM ImmunoTech, AI Proteins, Ajou University Medical Center, Akili Interactive Labs, Akome Biotech, Akoya Biosciences, Akron Children's Hospital, Akston Biosciences, Alamar Biosciences, Alaya.bio, Alberta Cell Therapy Manufacturing, Albert Einstein College of Medicine, ALBOT Technologies, Alcami, Aleta Biotherapeutics, Alexander Shulgin Research Institute, Alexandria Venture Investments, Alexion Pharmaceuticals, Alex’s Lemonade Stand Foundation, Algernon Pharmaceuticals, Aligning Science Against Parkinson’s, Align Technology, Alimera Sciences, AliveCor, Alkemist Labs, ALK Positive, Allegheny General Hospital, Allelica, Allen Institute for Brain Science, Allen Institute for Immunology, AlleyCorp, Alliance for Regenerative Medicine, Alligator Bioscience, Allosteric Bioscience, Alloy Therapeutics, Alnylam Pharmaceuticals, Alpenglow Biosciences, ALPHA10X, Alpha Tau Medical, ALS Association, Alterity Therapeutics, Altoida, Altos Labs, Alveo Technologies, ALX Oncology, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Alzheon, ALZpath, Amazon Web Services, Ambiopharm, Amedisys, American Association for Cancer Research, American Association for the Study of Liver Diseases, American Cancer Society, American College of Cardiology, American College of Lifestyle Medicine, American Diabetes Association, American Heart Association, American Lung Association, American National Multiple Sclerosis Society, American Pharmaceutical Association, American Society of Clinical Oncology (ASCO), American Society of Gene and Cell Therapy, American Type Culture Collection (ATCC), American Urological Association, AmeriCares, Amgen, Amicus Therapeutics, AmMax Bio, Amneal Pharmaceuticals, Amnion Foundation, AMO Pharma, AmplifyBio, Amylyx Pharmaceuticals, AN2 Therapeutics, Anagram Therapeutics, ANANDA Scientific, Ancilia Biosciences, Andelyn Biosciences, Andy Hill CARE Fund, Anew Medical, Angany, Angel Yeast, Angers University, Angiogenesis Foundation, Anhalt University of Applied Sciences, Anixa Biosciences, Anji Pharma, Anju Software, Ankyra Therapeutics, Anova Enterprises, Anthony Nolan, Antios Therapeutics, Antisoma Therapeutics, Anumana, Apexigen, Aplastic Anemia & MDS International Foundation, Apmonia Therapeutics, Apollo Therapeutics, Applied Biomedical Science Institute, Applied Cells, Applied DNA Sciences, Applied Pharmaceutical Innovation, AppliedVR, Aprea Therapeutics, Aptinyx, Aptitude Medical Systems, Aptorum Group, ARCA Biopharma, Arcade Therapeutics, Arch Biopartners, Archeus Technologies, Arctic Therapeutics, Arctic University of Norway, Arctic Vision, Ares Genetics, Argonaut Manufacturing Services, Ariadne Genomics, Aridis Pharmaceuticals, Arima Genomics, Arizona State University, Arkansas Children's Research Institute, Arkansas Childrens Hospital, Arovella Therapeutics, Arrevus, Artelo Biosciences, Artidis, Artios Pharma, Artiria Medical, Artis BioSolutions, Artizan Biosciences, Arzeda, Asan Medical Center, Ascensia Diabetes Care, ASC Therapeutics, Asensus Surgical, Asep Medical, Ashion Analytics, ASH Research Collaborative, Asia Green Biotechnology, Asklepios Biopharmaceutical, Aslan Pharma, Aspect Biosystems, Aspira Scientific, Assistance Publique-Hôpitaux de Paris, Association for Frontotemporal Degeneration, Association for the Advancement of Blood & Biotherapies, Associazione Poic e Dintorni APS, Astarte Medical, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, Astrin Biosciences, ATAI Life Sciences, Atara Biotherapeutics, Athenex, Athersys, Athos Therapeutics, Atomo Diagnostics, ATP, Atreca, ATUM, Audere, Augusta University Health, AUM LifeTech, AuraVax Therapeutics, Aurobindo Pharma, Australian and New Zealand Children’s Haematology / Oncology Group, Australian Genome Research Facility, Australian Nuclear Science and Technology Organisation, Australian Research Council, Autobahn Labs, Avalon Action Alliance, Avenue Therapeutics, Aveta Biomics, Avicanna, Aviceda Therapeutics, Avid Bioservices, Avidea Technologies, Avidity Biosciences, AVM Biotechnology, Awakn Life Sciences, AWAK Technologies, Axelys, AXIM Biotechnologies, Ayala Pharmaceuticals, Azome Therapeutics, Babraham Institute, Banner MD Anderson Cancer Center, Baptist Health Care, Barbara Ann Karmanos Cancer Institute, Barinthus Biotherapeutics, Barrow Neurological Institute, Barth Syndrome Foundation, Bascom Palmer Eye Institute, Basilea Pharmaceutica, Baszucki Brain Research Fund, Bateman Horne Center, Battelle, Battelle Memorial Institute, Bayer, Baylor College, Baylor College of Medicine, Baylor Scott and White Research Institute, B Braun, BC Platforms, Beactica, Beckman Research Institute of City of Hope, Becton Dickinson, Beijing Illness Challenge Foundation, Beijing University of Chinese Medicine, Beijing Xisike Clinical Oncology Research Foundation, Belgian Society of Medical Oncology, Bellicum Pharmaceuticals, Ben-Gurion University, Benaroya Research Institute, Beryl Institute, Bespoke Gene Therapy Consortium, Beth Israel Deaconess Medical Center, BetterLife Pharma, Better Therapeutics, Beyond Air, Beyond Batten Disease Foundation, Beyond Cancer, Beyond Type 1, Bharat Biotech, BICO, Bicycle Therapeutics, Bielefeld University, Bill and Melinda Gates Foundation, Binghamton University, Bio-Manguinhos/Fiocruz, Bio-Rad Laboratories, Bio-Techne, BioAesthetics, BIOASTER, Biobeat, Biocaptiva, Biocartis, Biocon, BioCopy, Biodesix, BioEclipse Therapeutics, Biofabri, Biofourmis, Biogen, Biohaven Pharmaceuticals, BIOHM Health Inc, BioIntelliSense, BiolineRX, BioLink Life Sciences, Biological Dynamics, BiologIC Technologies, BioMarin Pharmaceutical, BioMark Diagnostics, BiomeBank, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), BioMed X Innovation Center, bioMerieux, Biomica, Biomodex, Biomunex Pharmaceuticals, BiomX, BiondVax, BioNTech, BioRestorative Therapies, BioSig Technologies, BioSkryb, BioVaxys, Biovo Technologies, BioXcel, BIRAD Research and Development Company, Bird Foundation, bitBiome, BiVACOR, Blackrock Neurotech, Bloom Science, Blu Biotech, Blue Earth Diagnostics, Blue Note Therapeutics, Blueprint Medicines, Blue Water Vaccines, Blumentech, Boehringer Ingelheim, Bohai Biomedical, Boomer Esiason Foundation, BostonGene, Boston Immune Technologies and Therapeutics, Boston Scientific, Boston University, Boundless Bio, BPGbio, BRAINBox Solutions, Brain Canada, Brain Cancer Canada, Brain Research Through Advancing Innovative NeurotechnologiesInitiative, Brain Trauma Foundation, Breakthrough Discoveries for Thriving with Bipolar Disorders Foundation, Breakthrough Genomics, Breast Cancer Canada, BriaCell Therapeutics, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, Brightseed, Bristol-Myers Squibb, Broad Clinical Labs, Broad Institute, Broken String Biosciences, Brooks Rehabilitation, Brotman-Baty Institute, Brown University, Buck Institute for Age Research, Bugworks, Bumrungrad International, Burke Neurological Institute, Busan Paik Hospital, Butantan Institute, C2N Diagnostics, Cabaletta Bio, Cadila Pharmaceuticals, Cala Health, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, Camino Pharma, Canadian Cancer Society, Canadian Institutes of Health Research, Canadian Neuromuscular Disease Registry, CANbridge Pharmaceuticals, CancerCare, Cancer Focus Fund, Cancer Hospital Chinese Academy of Medical Sciences, Cancer Prevention and Research Institute of Texas, Cancer Research Horizons, Cancer Research Institute, Cancer Research UK, Cancer Science Institute of Singapore, CancerVax, CancerX initiative, Candel Therapeutics, Cannex Scientific, Canon BioMedical, Cantabio Pharmaceuticals, Cantex Pharmaceuticals, Capitainer, Capricor Therapeutics, Caprisa, Caraway Therapeutics, CARB-X, Cardea Bio, Cardiff University, Cardiomatics, CARE, Care4Rare Consortium, CareDx, CarePoint Health, Caribou Biosciences, Carilion Clinic, Caring Cross, Caris Life Sciences, Carisma Therapeutics, Carleton University, Carlsmed, Carl Zeiss, Carnegie Mellon University, Carterra, CARTI Cancer Center, Case Western Reserve University, Cassava Sciences, Cassie + Friends, Castle Biosciences, Castle Creek Biosciences, Catalyst Clinical Research, Catamaran Bio, Catholic University Leuven, cbdMD, CDISC, Ceapro, Cedars-Sinai Medical Center, Cegedim, Celanese, Celcuity, Celdara Medical, Celiac Disease Foundation, Cell and Gene Therapy Catapult, CellBion, Cellevolve Bio, Cell Mogrify, Cellpath, CellProThera, Cell Signaling Technology, Cell Therapy Manufacturing Center, Celltrion, Celonic, Center for Aquaculture Technologies, Center for Breakthrough Medicines, Center for Cancer and Blood Disorders, Center for Contemporary Sciences, Center for Genomic Regulation, Centers for Disease Control and Prevention, Centivax, Centogene, Central Institute for Experimental Animals, Centre for Addiction and Mental Health, Centre for Clinical Cancer Research, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Human Drug Research, Centre for Probe Development and Commercialization, Centre Hospitalier Universitaire Vaudois (CHUV), Centre Leon Berard, Cerba HealthCare, Cerecin, Cerecor, Certara, Certified Endoscopy, Certintell, CGIAR International Livestock Research Institute, Champalimaud Foundation, Champions Oncology, Chang Gung University, Chan Zuckerberg Initiative, Chao Center, Charak Foundation, Charcot-Marie-Tooth Association, Charite-Universitatsmedizin, Charite Universitatsmedizin Berlin, Charles River Laboratories, Charlotte's Web, CHDI Foundation, ChemDiv, ChemGenes, ChemImage, Chemomab Therapeutics, Children's Hospital at Montefiore, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Michigan Foundation, Children's Hospital of Orange County, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's Mercy Hospital, Children's National Hospital, Children's Tumor Foundation, Children´s Oncology Group (COG), Chimeric Therapeutics, China Agricultural University, Chinese University of Hong Kong, Chonnam National University, Choroideremia Research Foundation, Christopher & Dana Reeve Foundation, ChromaCode, Chroma Medicine, Chrysalis BioTherapeutics, Chubu University, CHUM Research Centre, CHU Sainte-Justine, Cimeio Therapeutics, Cincinnati Children’s Hospital Medical Center, Cipla, Circular Genomics, Citizens United for Research in Epilepsy, City College of New York, City of Hope, Civica Rx, Clario, Claritas HealthTech, Clarity Pharmaceuticals, Clarix, Clarus Therapeutics, Clearmind Medicine, ClearPoint Neuro, Clene Nanomedicine, Cleveland Clinic, Cleveland University Hospitals, Climate Amplified Disease and Epidemics, ClinEdge, Clinical Laserthermia Systems (CLS), Clinical Registry Investigating Bardet-Biedl Syndrome, Clinton Health Access Initiative, Clover Biopharmaceuticals, CMT Research Foundation, CN Bio, CND Life Sciences, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Coalition for the Advancement of Research and Innovation in Trauma, CoapTech, Coave Therapeutics, CobiCure MedTech, CoBTeK, Codetta Biosciences, Codex DNA, Codiak BioSciences, Coeptis Therapeutics, Cofactor Genomics, Cognition Therapeutics, Cognito Therapeutics, Cognoa, Cohen Veterans Bioscience, CoImmune, Cold Spring Harbor, Collplant, Colorado Center for Personalized Medicine, Colorado Melanoma Foundation, Colorado State University, Colors Farm, Columbia University, Columbia University Medical Center, Combangio, Combat Stress, Community Health Systems, COMPASS Pathways, Compentex, Complutense University of Madrid, Conagen, ConcertAI, Concordia University, Concr, Cone Health, ConserV Bioscience, Context Therapeutics, Cooper Companies, COPD Foundation, Copernicus Therapeutics, Core Biotherapeutics, Core One Labs, Coretec Group, Corewell Health, Cornell University, Corteva Agriscience, COVAX, Coya Therapeutics, CPI International, Creative Medical Technologies, Crescendo Biologics, Critical Path Institute (C-Path), Croda, Crohn's and Colitis Foundation of America, CRT Pioneer Fund, CSEM Centre Suisse d'Electronique et de Microtechnique, CSIR-Central Drug Research Institute, CSIR - Institute of Microbial Technology, CSIRO, Cubresa, Cullinan Oncology, Cultivarium, Curate Biosciences, Cure AP-4, Curebase, Cure Duchenne, Cure Network Dolby Acceleration Partners, CurePSP, Curetis, CureVac, Curiox Biosystems, Curis, Curreio, CurveBeam AI, CV Sciences, Cybrexa Therapeutics, Cyclica, Cyclo Therapeutics, CYduct Diagnostics, Cyrus Biotechnology, Cystic Fibrosis Foundation, Cytecare Cancer Hospitals, Cytek Biosciences, Cytiva, Cytocom, CytoImmune Therapeutics, CytoMed Therapeutics, CytoRecovery, Cytovation, D&D Pharmatech, Daiichi Sankyo, Dalhousie University, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, Danaher, Danish Cancer Society Research Center, Dante Labs, Dare Bioscience, Dartmouth College, Dassault Systems, DaVita, Day One Biopharmaceuticals, DCN Diagnostics, DDN, Deakin University, Deargen, Debiopharm, Decibel Therapeutics, Decoy Therapeutics, dEEGtal Insight, Deep Bio, Deepcell, Deep Science Ventures, Deerfield Management, Defence Therapeutics, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delfi Diagnostics, Delphi Diagnostics, DelSiTech, Dementia Research Institute, Denso, Department of Defense, Department of Energy, Department of Health - Abu Dhabi, Department of Health and Human Services, Department of Public Health, Derm-Biome Pharmaceuticals, DermTech, Detect-Ion, DevPro Biopharma, DevsHealth, Dewpoint Therapeutics, Diabetes Research Connection, Diabetes Research Institute, DiagnaMed, Dialectic Therapeutics, Diamond Therapeutics, Diamyd Medical, Diana Davis Spencer Foundation, Digital Medicine Society, Digital Therapeutics Alliance, DiNAQOR, DiosCURE Therapeutics, DIOSynVax, Disability Solutions, DoctorsOne Healthcare Systems, Domain Therapeutics, DoMore Diagnostics, Dovetail Genomics, Drake University, Drexel University, Drug Farm, Drugs for Neglected Diseases Initiative, DTx Pharma, Duke-NUS Graduate Medical School Singapore, Duke Clinical Research Institute (DCRI), Duke University, Duke University Health System, Duke University Medical Center, Dutch SAZ, Dyadic International, Dynavax Technologies, Dyve Biosciences, DZNE German Center for Neurodegenerative Diseases, Eagle Genomics, Early is Good, Eastern Michigan University, Eckerd College, Eclipse, ECM Therapeutics, Ecole Polytechnique de Montreal, Ecole Polytechnique Federale de Lausanne, ECRI Institute, Edan Instruments, Edesa Biotech, EdiGene, eFFECTOR Therapeutics, Eikonoklastes Therapeutics, Eisai, Elaaj Bio, Elanco, Elasmogen, Eleanor Crook Foundation, ElectroCore, Elephas, Elevai Labs, ElevateBio, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Eloxx Pharmaceuticals, Elpis Biopharmaceuticals, Elute, Elysium Health, Embleema, Emcure Pharmaceuticals, Emendo Biotherapeutics, Emit Imaging, Emocha Mobile Health, Emory University, Emovi, ENA Respiratory, Endeavor BioMedicines, Endoluxe, ENDRA Life Sciences, Engimmune Therapeutics, Engrail Therapeutics, Enlivex, Enosis Therapeutics, ENPICOM, Enterin, Enterome Bioscience, Enterprise Ireland, Entos Pharmaceuticals, Entrada Therapeutics, Enveric Biosciences, Envisagenics, EpicentRx, Epicypher, Epilepsy Canada, Epilepsy Foundation (EF), Epiphany Dermatology, EpiPointe, Epistemic AI, Epivax, Equillium, Erasca, Erasmus University Medical Center, Erlangen University Hospital, ERS Genomics, EspeRare Foundation, Esperovax, Essent Biologics, Essen University Hospital, Estee Lauder, Eterna Therapeutics, eTheRNA immunotherapies, Ethris, Etienna Bio, Eunice Kennedy Shriver Institute of Child Health and Human Development, Euratom, Eureka Eurostars, Eureka Therapeutics, Eurofins Scientific, Eurofins Viracor, European Institute of Oncology (EIO), European Laboratory for Particle Physics, European Organization for Research and Treatment of Cancer, European Society for Organ Transplantation, European Union, European Wellness Biomedical Group, Everest Medicines, Evergreen Theragnostics, EverythingALS Open Innovation Consortium, EVerZom, Evogene, EvolveImmune Therapeutics, Evonetix, EVOQ Therapeutics, Evotec, Evox Therapeutics, Exacis Biotherapeutics, Exact Sciences, Exagen Diagnostics, ExcellGene, Excision BioTherapeutics, Exicure, EXoPERT, Exousia Pro, Expansion Therapeutics, Experimental Drug Development Centre, Experimental Therapeutics Centre of Singapore, ExPLoRNA Therapeutics, Exscientia, Exuma Biotech, Eyam Vaccines and Immunotherapeutics, Eyedea Medical, Facit, FairJourney Biologics, Falk Medical Research Trust, Family Reach, FatiAbGen, Fauna Bio, Federation Bio, Feinstein Institute for Medical Research, Feldan Therapeutics, Felix Biotechnology, Ferronova, Fight Colorectal Cancer, FightMND, Finch Therapeutics, Find Therapeutics, FINGERS Brain Health Institute, Finnish Institute for Health and Welfare, FivepHusion, Flagship Pioneering, Flatiron Health, Flightpath Biosciences, Florica Therapeutics, Florida Atlantic University Research, Florida Cancer Specialists & Research Institute, Florida International University, Florida State University, Flow Eighteen38, Fluidigm, Follicular Lymphoma Foundation, Fondation Cancer, Fondazione Telethon, Food Allergy Research & Education, Food and Drug Administration (FDA), Forever Healthy Foundation, Forge Biologics, Forsyth Institute, FortySix Venture Capital, Fosun Pharmaceutical, Foundation Fighting Blindness, Foundation for Diabetes Research, Foundation for Innovative New Diagnostics, Foundation for Neglected Disease Research, Foundation for Sarcoidosis Research, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Fox Chase Cancer Center, Francis Crick Institute, Fraunhofer Institute for Cell Therapy and Immunology, Fraunhofer Institute for Molecular Ecology (IME), Fred Hutchinson Cancer Research Center, Fresenius Kabi Pharmaceuticals, Friedreichs Ataxia Research Alliance, FSD Pharma, FSHD Global Research Foundation, Fujifilm, Fujifilm Irvine Scientific, Fujirebio Diagnostics, Fukuoka Tokushukai Hospital, Fulgent Pharma, Fuse Oncology, Fusion Pharmaceuticals, FuturaGene, Fuzionaire, Fuzionaire Diagnostics, FYR Diagnostics, Gan & Lee, Gastro-Intestinal Research Foundation, Gates Medical Research Institute, Gateway for Cancer Research, GAVI Alliance, Gazi University, GBS, GC Pharma, GE Healthcare, GEICAM, Geisinger Health System, Gemelli Teaching Hospital, GemPharmatech, GEn1E Lifesciences, Genascence, Gene Bio Medical, Gene by Gene, Genedrive, GeneDX, Geneial, Genentech, Generate Biomedicines, Generation Bio, Generex Biotechnology, Genestack, Genethon, Genetic Alliance, Genetic Analysis, Genetic Cures for Kids, GeNeuro, Geneva Foundation, Genialis, Gennao Bio, Genomadix, Genome Insight, Genomes2People, Genomic Biopharma, Genomics England, Genoscience, genOway, Genprex, Gensaic, GenScript Biotech, GenScript ProBio, Georges Francois Leclerc Center, Georgetown University, George Washington University, Georgia Institute of Technology, Georgian Bay General Hospital, Georgia State University, GeoSeeq Foundation, German Cancer Research Center, German Center for Infection Research, German Heart Centre Berlin, Ghent University, Giiant Pharma, Gilbert Family Foundation, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, GlamorousAI, Glaucoma Research Foundation, Glenmark Pharmaceuticals, Global Access Diagnostics, Global Alzheimer's Platform (GAP), Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Technology, Global Center for Health Innovation, Global Coalition for Adaptive Research, Global Down Syndrome Foundation, Global Genes, Global Health Labs, Global Liver Institute, Global Virus Network, Glooko, GlycoMantra, GlycoPath, Glycotope Biotechnology, Glytherix, GNS Healthcare, GO2 Foundation for Lung Cancer, GOG Foundation, GondolaBio, Google, Gradalis, Grail, Graph Therapeutics, GrayMatters Health, Great Ormond Street Hospital (GOSH), Greenlight Biosciences, Greenwich LifeSciences, Grey Wolf Therapeutics, GRI Bio, Griffith University, Gritstone Bio, Grunenthal, GSK, GT Biopharma, Guangdong Academy of Medical Sciences, Guardant Health, Guardian Research Network, Gusto Global, Guys and St Thomas NHS Foundation Trust, Gyroscope Therapeutics, H1, Hackensack Meridian Health, Hadassah Brain Labs Center, Hadassah Medical Center, HaemaLogiX, Haihe Laboratory of Cell Ecosystem, Halberd, HalioDx, Halomine, Hannover Medical School, Harbinger Health, Harbour Biomed, Harvard Apparatus Regenerative Technology, Harvard College, Harvard Medical School, Harvard University, Hatchleaf, Haukeland University Hospital, HAYA Therapeutics, Haystack Oncology, Hazelden Betty Ford Foundation, HCA Healthcare, HCW Biologics, HDT Bio, Healint, Healis Therapeutics, Health Holland, HealthTrackRx, Healthy.io, HeartSciences, Hebrew University of Jerusalem, Heligenics, Helio Genomics, Helius Medical Technologies, Helix, Helmholtz Zentrum Munchen, Helocyte, Hemanext, Henan Cancer Hospital, Henry Ford Health System, Henry M. Jackson Foundation, Henry Schein, HepaTx, Hereditary Neuropathy Foundation, Hetero India, Hibiscus BioVentures, Hikma Pharmaceuticals, Hillstream BioPharma, Histogen, HistoIndex, Hoboken University Medical Center and Christ Hospital, Hoffmann La Roche, Hokkaido University, Holmusk, Hologic, Hong Kong Genome Institute, Horizon Europe, Horizon Therapeutics, Hospital Clinic of Barcelona, Hospital for Sick Children, Hospital for Special Surgery, Hoth Therapeutics, Houston Methodist Research Institute, HTG Molecular Diagnostics, Hubei Academy of Agricultural Sciences, Hubrecht Institute, Hudson-Alpha Institute for Biotechnology, Hudson Institute of Medical Research, Humacyte, Human Cell Atlas, Humanigen, Humanitas University, Hummingbird Bioscience, Hunterian Medicine, Hyperfine Research, Hypersomnia Foundation, IAMA Therapeutics, IBA, Ibex Medical Analytics, IBM, Icahn School of Medicine at Mount Sinai, Icometrix, Icosavax, IdentifySensors Biologics, iECURE, IGC Pharma, IGM Biosciences, IgniteData, IHI, IIT-Istituto Italiano di Tecnologia, Ikena Oncology, Ikonisys, Iktos, iLAC, Ilias Biologics, Illumina, IMIDomics, Immix Biopharma, ImmPACT Bio, ImmuneID, Immunicom, Immunis, ImmunityBio, ImmunoAdoptive Cell Therapy, Immunocore, ImmunoForge, ImmunoGenesis, Immunome, ImmunoScape, Immuron, Immusoft, Immutep, Immuthera, IMPACT-AML, ImPact Biotech, Imperial College London, Imugene, IN8bio, INADcure Foundation, Inagene Diagnostics, Incannex Healthcare, Inceptor Bio, Indee Labs, Indiana University, Indica Labs, Indivumed, Infection Innovation Consortium, Infex Therapeutics, Informatica, InformedDNA, Inhalon Biopharma, Inhibitor Therapeutics, Inimmune, Inivata, INmune Bio, InnarisBio, InnDura Therapeutics, Innoplexus, Innosuisse, Innovate UK, Innovative Medicines Initiative (IMI), Inocras, Inotrem, Inozyme Pharma, Inserm, Inserm Transfert, InSightec, Insilico Medicine, Insitro, InSitu Biologics, Inspira Technologies, InspireMD, Institut Bergonie, Institut Curie, Institute for Bioscience and Biotechnology Research, Institute for Follicular Lymphoma Innovation, Institute for Life Changing Medicines, Institute for Molecular Medicine, Institute for Molecular Medicine Finland, Institute for Protein Innovation, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute of Cancer Research, Institute of Molecular and Clinical Ophthalmology Basel, Institute of Neurodegenerative Diseases, Institute of Oncology Research, Institute of Organic Chemistry and Biochemistry, Institute of Virology and Immunology, Institut für Hämopathologie Hamburg, Institut Gustave Roussy, Institut Imagine, Institut Kanser Negara, Institut Merieux, Institut National Recherche Agronomique, Instituto de Biologia Experimental e Tecnológica, Instituto de Microecologia, Institut Paoli-Calmettes, Institut Pasteur, Integrated Biosciences, Integra Therapeutics, IntelGenx, Intelligent Medical Objects, Intelligent Scopes, Intensity Therapeutics, Intermountain Healthcare, International Association for the Study of Lung Cancer, International Center for Genetic Engineering and Biotechnology, International Diabetes Federation (IDF), International Hyperhidrosis Society, International Isotopes, International Niemann-Pick Disease Registry, International Panel Physicians Association, International Society for Heart and Lung Transplantation, International Society of Heart and Lung Transplantation, International Spine Study Group Foundation, InterVenn, Intonation Research Laboratories, InTouch Health, Intravacc, IntrinsiQ, Invectys, Inventiva, Inventprise, Inventum Genetics, invIOs, InvisiShield Technologies, InVivoScribe, InVixa, iOnctura, Ionian University, IQVIA, IRBM, IRLAB, Irras, ISA Pharmaceuticals, IsoPlexis, Isotopia Molecular Imaging, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, ITM Isotopen Technologien, iTolerance, IUCT, Ixaka, Jackson Laboratory, Jaeb Center for Health Research Foundation, James Hutton Institute, JanOne, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Japanese Foundation for Cancer Research, Jasper Therapeutics, Javara, Jazz Pharmaceuticals, Jefferson Healthcare, Jeffrey Modell Foundation, JelloX Biotech, Jenner Institute, Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Jesse's Journey, Jhpiego, Jiangxi Province Institute of Materia Medica, Jikei University, Jinggangshan University, J Ints Bio, Johannes Gutenberg University, John Hopkins University School of Medicines, Johnny Carson Foundation, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Joint BioEnergy Institute, Jomo Kenyatta University of Agriculture and Technology, Josep Carreras Leukaemia Research Institute, Joslin Diabetes Center, Jubilant Biosys, Jubilant Therapeutics, Jumpcode Genomics, Juntendo University, Jupiter Wellness, Juvena Therapeutics, Juvenile Bipolar Research Foundation, Juvenile Diabetes Research Foundation, K2M, Kabuki Syndrome Foundation, Kadimastem, Kahn-Sagol-Maccabi, KAHR Medical, Kaleido Biosciences, Kallyope, Kane Biotech, KangWon University Institute of Medical Science, Kansas State University, Kansas University Medical Center (KUMC), Kantonsspital Baselland, Kantonsspital St. Gallen, Kanvas Biosciences, KARE Biosciences, Karolinska Institute, Karolinska University Hospital, Kazia Therapeutics, KDx Diagnostics, Keck Graduate Institute of Applied Life Sciences, Keck School of Medicine of USC, KeifeRx, Keio Gijuku University, Kelai Pharmaceuticals, Keller Army Hospital, Kempelen Institute of Intelligent Technologies, KemPharm, Kennedy Institute of Rheumatology, Kennedy Krieger Institute, kENUP Foundation, Kenya Medical Research Institute, Kheiron Medical Technologies, Kidney Innovation Accelerator, KIF1A, Kimer Med, Kincell Bio, Kineta, King Abdullah International Research Center, King Abdullah University for Science and Technology, Kings College London, Kinnear Pharmaceuticals, Kintara Therapeutics, Kiora Pharmaceuticals, Kiromic Biopharma, KK Women’s and Children’s Hospital, Koneksa Health, Korea Institute of Radiological and Medical Sciences, Korrus, Krankenhaus Nordwest, Kriya Therapeutics, Kubota Vision, Kumamoto University, Kura Oncology, KWF, Kyoto University, Kyowa Hakko Kirin, Kytopen, Kyttaro, Kyushu University, Kyverna Therapeutics, Laboratory Corporation of America, Laboratory of Pathology, Lahey Hospital & Medical Center, La Jolla Institute for Allergy & Immunology, La Jolla Labs, Landmark Bio, Landos Biopharma, Langara College, Lantern Pharma, Lassen Therapeutics, Last Chance for Children, Latvian Institute of Organic Synthesis, Laurus Labs, Lawrence Livermore National Laboratory, Lawson Health Research Institute, Laxxon Medical, Lazurite, Le Bonheur Children's Hospital, Lee Moffitt Cancer Center, Lehigh Valley Health Network, Leibniz-Institut fur Molekulare Pharmakologie, Leiden University, Leidos, Leinco Technologies, Lenire Biosciences, Lepton Pharmaceuticals, Leucid Bio, Leukemia & Lymphoma Society, Levitee Labs, LEXEO Therapeutics, Lieber Institute, LifeArc, LifeBio, Lifebit Biotech, Life Edit Therapeutics, Life Raft Group, Lifespin, LIfT BioSciences, LightDeck Therapeutics, LimmaTech Biologics, Lineage Cell Therapeutics, LinKinVax, Linnea Cannabinoids, Linus Biotechnology, LipoVac, Lisa Dean Moseley Foundation, Little Warrior Foundation, LiveRx Research Group, Lixte Biotechnology, LogicInk, Loma Linda University, London Health Sciences Centre, London School of Medicine and Dentistry, Longeveron, Long Island University, Longwood University, LoQus23 Therapeutics, Louisiana State University, Loulou Foundation, LSU Health Sciences Center, Lucence, Lucid Psycheceuticals, Lucy Scientific Discovery, Lucy Therapeutics, Ludwig-Maximilians University, LumaBridge, Lumen Biomedical, Lumoptik, Lumos Pharma, Lunaphore, Lundbeck, Lundquist Institute, Lund University, Lung Cancer Foundation of America, Lung Cancer Research Foundation, LUNGevity Foundation, Lunit, Lupus Canada, Lupus Foundation of America (LFA), Lupus Research Alliance, Lupus Therapeutics, Lustgarten Foundation, Lutris Pharma, Luxel, Luxembourg National Research Fund, Lymphoma Academic Research Organization, Lysogene, Lytix Biopharma, Maastricht University, Maccabi Healthcare Services, Macleods Pharmaceuticals, Macquarie University, Macrostruct Holding & Consulting, Magruder Eye Institute, Mahidol University, MAIA Biotechnology, Maine Medical Center, Mainz Biomed, Mainz University Medical Centre, Mair Therapeutics, Makana Therapeutics, Mandos, Manhattan BioSolutions, Manny Pacquiao Foundation, March of Dimes, Marengo Therapeutics, Maria Curie-Sklodowska University, Marinus Pharmaceuticals, Marker Therapeutics, Mark Foundation for Cancer Research, Marshfield Clinic, Mary Crowley Cancer Research Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, MassRobotics, Matai Medical Research Institute, Mater Research, Matica Biotechnology, MatriSys Bioscience, Max-Delbruck Center for Molecular Medicine, Max-Planck, Max Biopharma, Max Foundation, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, Mayo Clinic BioPharma Diagnostics, McGill University, McKesson, McLean Hospital, McMaster University, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MDClone, MDxHealth, MedAxiom, MEDIAN Technologies, Medical City North Hills, Medical College of Georgia, Medical College of Wisconsin, Medical College of Wisconsin Neuroscience Institute, Medical iSight, Medical Research Council, Medical University of Graz, Medical University of Innsbruck, Medical University of South Carolina, Medical University of Vienna, Medical University South Carolina, Medicines Discovery Catapult, Medicines Patent Pool Foundation, MediciNova, MediGene, MediMergent, MedinCell, MediPharm Labs, Medlab Clinical, Medline Industries, MedShape, Medtronic, Medx, Meharry Medical College, Meilleur Technologies, Melanoma Research Alliance, Melax Technologies, Memorial Sloan Kettering Cancer Center, Menon Biosensors, Mentice, Merck and Co, Merck KGaA, Mereo BioPharma, Merus, Mestag Therapeutics, Metabolon, Metagenomi, MetaSight Diagnostics, Methodist Hospital Houston, Mevion Medical Systems, MGFB, MGI Tech, Michael J Fox Foundation, Michal Morrison, Michigan Medicine, Michigan State University, Microbion, Microbot Medical, Micronoma, Microsoft, Microviable Therapeutics, MigVax, MILA International, Milken Institute Center for Public Health, Millennium, MilliporeSigma, Milner Therapeutics Institute and Consortium, MiMedx, MindMaze, Mindset Pharma, MiNK Therapeutics, MIP Discovery, miraDry, Mirati Therapeutics, miRecule, Mirimus, Miromatrix Medical, Mission Bio, Mission Therapeutics, Mitacs, MitoCanada Foundation, Mitochondrial Innovation Initiative, Mitochon Pharmaceuticals, MitoSense, Mitsubishi Tanabe Pharma, MJH Life Sciences, Model Medicines, Moderna, Modifi Bio, Mohamed bin Zayed University of Artificial Intelligence, Mohammed VI Polytechnic University, Molecular Biology Systems, Molecular Targeting Technologies, Moleculin Biotech, Moligo Technologies, Monash University, Monopar Therapeutics, Montefiore Health System, Monte Rosa Therapeutics, Montreal Heart Institute, Morehouse School of Medicine, Morris Animal Foundation, Mosaic ImmunoEngineering, Mount Sinai Health System, Mount Sinai Medical Center, Movendo Technology, MPM Capital, mProbe Laboratories, mPulse Mobile, MRIGlobal, MSN Pharmaceuticals, Multidisciplinary Association for Psychedelics Studies, Multiple Myeloma Research Foundation, Multiple Sclerosis Society of Canada, Multiply Labs, Munich Reinsurance Company, Munich Technical University, Muscular Dystrophy Association, Mustang Bio, MyBiotics Pharma, MyClearStep, Mydecine Group, myDNA, MyMD Pharmaceuticals, MYND Life Sciences, MyndVR, myNEO, Myosana Therapeutics, Myotonic Dystrophy Clinical Research Network, Myovant Sciences, Myriad Genetics, Myrobalan Therapeutics, n-Lorem Foundation, Nagoya University Graduate School of Medicine, Nanite, NanoDx, Nanoform, Nanoscope Therapeutics, NanoString Technologies, NaNotics, NanoView Biosciences, Nascent Biotech, Nashville Biosciences, NATA, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Cerebral and Cardiovascular Disease Research Center, National Cheng Kung University, National Comprehensive Cancer Network (NCCN), National Disease Research Interchange, National Eye Institute, National Health and Medical Research Council, National Healthcare Services (NHS), National Health Service, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Health and Care Research Respiratory Translational Research Collaboration, National Institute for Health Research (NIHR), National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Food and Agriculture, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Nursing Research, National Institute of Standards and Technology, National Institute on Aging, National Institute on Deafness and Other Communication Disorders, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Jewish Health, National Organization for Rare Disorders, National Research Council Canada, National Resilience, National Science Foundation, National University Cancer Institute, National University of Ireland, Galway (NUI Galway), National University of Singapore, Nationwide Children’s Hospital, Natural Sciences and Engineering Research Council of Canada, Nautilus Biotech, Naval Medical Research Center, Naveris, Navidea Biopharmaceuticals, Navrogen, NED Biosystems, Negev Labs, Nektar Therapeutics, NemaLife, Neochromosome, Neogen, Neogene Therapeutics, Neoleukin Therapeutics, NeoPhore, Nephria Bio, NephroDI Therapeutics, NervGen Pharma, Netherlands Cancer Institute, NetraMark, NETRIS Pharma, NeuCyte, Neumora Therapeutics, NeuraLight, NeurAxis, Neuro42, Neurodex, Neurodon, Neurogene, NeuroGenesis, NeuroLogica, Neurona Therapeutics, Neuronic, Neuropore Therapies, NeuroSense Therapeutics, NeuroTrauma, NeuroVision Imaging, Neutron Therapeutics, Newcastle University, Newel Health, New Hope Research Foundation, New Horizon Biotech, Newly Institute, NewStem, New West Genetics, New York Institute of Technology, New York Presbyterian/Columbia, New York Structural Biology Center, New York University, New York University Langone Health, New York University School of Medicine, Nexel, Neximmune, Next Generation Manufacturing Canada, NextVivo, Niagen Bioscience, Nico, NIMML Institute, NImmune Biopharma, Nitto Avecia, NKGen Biotech, Nona Biosciences, Nonacus, Nordic Nanovector, Nordic Society of Gynaecological Oncology, North Carolina Central University, North Carolina Collaboratory, North Carolina State University, Northeastern University, Northwell Health, Northwest Biotherapeutics, Northwestern University, Norwegian Cancer Society, Norwegian University of Science, Nottingham University Hospital, NovAccess Global, NovAliX, Novanta, Novartis, Novartis Institutes for BioMedical Research, Novavax, Novocure, Novo Nordisk, NOWDiagnostics, Noxopharm, NRC Health, NRG Therapeutics, NRx Pharmaceuticals, NTT Data, NTT Medical Center Tokyo, NTx, Nucleai, Nucleix, Nucleus Biologics, Nucleus RadioPharma, Nucore Medical, NuGenerex Immuno-Oncology, Numares, Nuravax, Nurix Therapeutics, Nurosene, NuVasive, Nuvectis Pharma, Nuvisan Pharma Services, Nuvo Group, Nvidia, NXgenPort, Nykode Therapeutics, NysnoBio, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Oak Ridge National Laboratory, Obatala Sciences, Ocean Biomedical, Ocugen, Oculogica, OhioHealth, Ohio State University, Oklahoma Medical Research Foundation, Olatec Therapeutics, Olimmune, Olink Proteomics, Olivia Newton-John Cancer Research Institute, Olon, Omega Therapeutics, Omico, Omnia, Omnicell, Omnilife Science, OmniSpirant, Omron, Oncidium Foundation, OncoArendi Therapeutics, Oncocross, Oncode Institute, OncoHost, Oncology Group, Oncolytics Biotech, OncoMyx Therapeutics, OncoNano Medicine, OncoResponse, Oncoshot, Oncternal Therapeutics, One Biosciences, ONI, ONK Therapeutics, Ono Pharmaceutical, Ontario Institute for Cancer Research, Onward Therapeutics, OpenFold Drug Discovery AI Research Consortium, Open Philanthropy, Optac-X, Optimi Health, Optina Diagnostics, Opus Genetics, Oracle, Oragenics, Orange Grove Bio, Orano Med, Orbus Therapeutics, Orebro University, Oregon Health Sciences University, Organicell Regenerative Medicine, OrganX, Orgenesis, Ori Biotech, OrigiMed, Origin Agritech, Orion Biotechnology, Orlando Health, Orphan Therapeutics Accelerator, OrsoBio, Orthopaedic Foot & Ankle Center, Ortho Regenerative Technologies, Oryzon, OSE Immunotherapeutics, Osel, OSI Systems, Osivax, Oslo University Hospital, Ossium Health, Ostentus Therapeutics, Osteopore International, OS Therapies, Oswaldo Cruz Foundation (Fiocruz), Otsuka, Ottawa Health Research Institute, Ottawa Hospital Research Institute, Outpace Bio, Oviva Therapeutics, Owkin, Oxford Biodynamics, Oxford BioMedica, Oxford Nanopore Technologies, Oxitec, Pacific Biosciences, Pacylex, Paige, Palantir, Paltown Development Foundation, Panbela Therapeutics, Pancreatic Cancer Early Detection Consortium, Pantherna Therapeutics, PanTher Therapeutics, Paragonix Technologies, Parent Project Muscular Dystrophy, Parexel, Parkinson's Disease Foundation, Parkinson's UK, Parkinsons Disease Foundation, Parse Biosciences, Particle, Partnership for Accelerating Cancer Therapies, Pasithea Therapeutics, PathAI, PathKeeper Surgical, PathMaker Neurosystems, Patient-Centered Outcomes Research Institute, PAVmed, PDS Biotechnology, PEAR Therapeutics, PECET, Peking Union Medical College, Penn Medicine, Penn State College of Medicine, Pennsylvania Biotechnology Center, Pennsylvania State University, Peptilogics, Peptone, PercayAI, Perrigo, Personal Genome Diagnostics, Personalis, Perspective Therapeutics, Peter Doherty Institute for Infection and Immunity, Peter MacCallum Cancer Institute, Pfizer, Pfizer Canada, PharmAla Biotech, PharmaTher, PharmEnable, Pharus Diagnostics, Phase Genomics, PhaseV, PHC, Phenomix, Phio Pharmaceuticals, Phoenix PharmaLabs, Phosplatin Therapeutics, PhysIQ, PicnicHealth, PierianDx, Pillar Biosciences, Pilloxa, PineTree Therapeutics, Pixie Dust Technologies, Plantae Biosciences, PlaqueTec, Pluri, Plus Therapeutics, Policlinico Gemelli, Politecnico University, PolyVascular, Pompeu Fabra University, Population Health Research Institute, Portal Bioscience, PostEra, Praedicare, Prairie Hub for Pandemic Preparedness, Precipio Diagnostics, PreciseDx, Precisio Biotix Therapeutics, PrecisionLife, Precision Molecular, Predictive Oncology, Prek Leap National Institute of Agriculture in Phnom Penh, Prenetics, Pressure BioSciences, Princess Margaret Hospital, Princeton University, Prisma Health, Pritzker Group, Privo Technologies, ProBioGen, Progenity, PrognomIQ, Project 8p Foundation, Project to Accelerate New Treatments for Tuberculosis, Prokarium, Propanc Biopharma, Propella Therapeutics, Prophase Labs, Proprio, ProQR Therapeutics, Prostate Cancer Clinical Trials Consortium, Prostate Cancer Foundation (PCF), ProteinLogic, Protelica, ProteoMediX, Proteomics International, Proton International, Provectus Biopharmaceuticals, Providence Cancer Institute, Providence Therapeutics, Proximie, Proxygen, Psilera, Psychedelic Society Belgium, Psyence Therapeutics, PTC Therapeutics, Pulmocide, PulmoSIM Therapeutics, Puma Biotechnology, Pumas-AI, Purdue Research Foundation, Purdue University, Purina, Purnovate, Purple Biotech, Q-Gen Cell Therapeutics, Qatar Foundation, QIAGEN, Qingdao Marine Biomedical Research Institute, Qnovia, QT Imaging, Quadram Institute, Qualigen, Quansys Biosciences, Quanterix, Quantum Leap Health Care Collaborative, Qu Biologics, Qubit Pharmaceuticals, Quebec Consortium for Drug Discovery, Quebec Heart and Lung Institute, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Queens University Belfast, Quercis Pharma, Quest Diagnostics, Quoin Pharmaceuticals, Qurient, Rabin Medical Center (Beilinson Hospital), Race Oncology, Ractigen Therapeutics, Radboud University Nijmegen, Radboud University Nijmegen Medical Centre, Radialogica, Radiopharm Theranostics, Radiopharm Ventures, Rady Children's Institute for Genomic Medicine, Rafa Laboratories, Ragon Institute, Raiden Science Foundation, Rainwater Charitable Foundation, Rakovina Therapeutics, Rambam Medical Center, Ramot at Tel Aviv University, Rapid Dose Therapeutics, RARE-X, Rarebase, Rarecells, RaySearch Laboratories, Ray Therapeutics, ReAlta Life Sciences, ReCode Therapeutics, Recover Together, Recurrent Respiratory Papillomatosis Foundation, Recursion, Redoxis, Reemo Health, Refuge Biotechnologies, Regel Therapeutics, Regeneron Genetics Center, RegenLab, Regenstrief Institute, Regenxbio, Regional Cancer Institute of Montpellier, Regulus Therapeutics, ReiThera, Remedium Bio, Remington Pharmaceuticals, Remission Medical, RenalytixAI, Renato Dulbecco Foundation, Renovaro BioSciences, Renovion, Rensselaer Polytechnic Institute, Repare Therapeutics, Repertoire Immune Medicines, Replay, Replicel Life Sciences, Research Council of Norway, Research Councils UK, Research to Prevent Blindness, Reset Pharmaceuticals, Resilience, Res Nova Bio, Resolution Bioscience, RespirAI Medical, Respira Technologies, RespireRx Pharmaceuticals, RetiSpec, Rett Syndrome Research Trust, Reveal Genomics, Revelation Biosciences, Revive Therapeutics, RevolKa, Rhinostics, Rhythm Pharmaceuticals, Rice University, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, RIGHT Foundation, Rigshospitalet, RIKEN Research Institute, RION, Risant Health, Rising Tide Foundation, RNA Disease Diagnostics, Robotic Biology Institute, Roche, Rockefeller University, Rocket VR Health, Rockley Photonics, Rockwell Medical, Roivant Sciences, Rokline Health Concepts, Rosalind Franklin University of Medical Sciences, Rose F Kennedy Intellectual and Developmental Disabilities Research Center, Roswell Park Cancer Institute, Rothamsted Research, Rothman Healthcare, Rothman Orthopaedic Institute, Royal College of Surgeons (Ireland), Royal Marsden Hospital, Royal Philips Electronics, RS BioTherapeutics, Rubedo Life Sciences, Rush University Medical Center, Russian Direct Investment Fund, Rutgers Cancer Institute of New Jersey, Rutgers University, RxCell, Ryerson University, Ryne Biotechnology, Sabin Vaccine Institute, Sable Therapeutics, Saga University, Saguaro Technologies, Saint Louis University, Saitama Medical University Hospital, Salarius Pharmaceuticals, SalioGen Therapeutics, Salk Institute, Sana Klinikum Offenbach, Sanara MedTech, SandboxAQ, Sanford Burnham Institute, Sanford Health, Sanofi, Sanofi-Pasteur, San Raffaele Hospital, Santa Clara University, Sant Joan de Déu-Barcelona Children’s Hospital, Sarah Cannon Research Institute, Sarawak Infectious Disease Centre, Sarcoma Oncology Center, Sarepta Therapeutics, Sartorius, Sartorius Stedim Biotech, SAS, Satellos Bioscience, Satio, Satisfai Health, SATT Conectus Alsace, SATT Nord, Savana, Scanslated, Scenic Biotech, Schrodinger, SciBase, Scientific Research Council, ScientificRT, Scintomics, Scipher Medicine, Scleroderma Research Foundation, Scripps Health, Scripps Research Institute, Scynexis, Sean M Healey & AMG Center for ALS, Seattle Children's Hospital, Seattle Childrens Research Institute, Secant Medical, Secarna Pharmaceuticals, Second Genome, Sectra, Seelos Therapeutics, Selagine, Select Medical, SELLAS Life Sciences Group, Selonterra, Selvita, Semmelweis University, Sen-Jam Pharmaceutical, SEngine Precision Medicine, Sensei Biotherapeutics, Senseonics, Sensifree, Sensus Healthcare, Sensyne Health, Seoul National University, Seqirus, Sequentify, Serenity Bioworks, Serosep, Serum Institute of India, Seven and Eight Biopharmaceuticals, Seven Bridges Genomics, Shamir Medical Center, Shanghai Institute of Materia Medica, Shanghai Jiao Tong University, Shanghai Public Health Clinical Centre, Sharp HealthCare, Sheba Medical Center, Sheffield Institute for Translational Neuroscience, Shepherd Therapeutics, Sherlock Biosciences, Shine Medical Technologies, Shionogi, Shirley Ryan AbilityLab, Shonan-Kamakura General Hospital, Shriners Hospital for Children, Shuttle Pharmaceuticals, Sibylla Biotech, Sichuan University, Sidney Kimmel Cancer Center, Siemens Healthineers, SIGA Technologies, Sigilon Therapeutics, Signify Health, Silo Pharma, SimBioSys, Simcere Pharmaceuticals, Simon Fraser University, Simris Biomimetics, Simulations Plus, Singapore Eye Research Institute (SERI), Singapore General Hospital, Singapore Sengkang General Hospital, Singleron Biotechnologies, Singular Genomics Systems, Sino-American Cancer Foundation, Sinomed, Sinovac Biotech, Sirion Biotech, Sirona Biochem, SiSaf, Sixty Degrees Pharmaceuticals, SKAN Research Trust, SK Biopharmaceuticals, SK Bioscience, Skin and Cancer Institute, Skip Therapeutics, Skive Hospital, Skylight Health, SkylineDX, Skymount Medical, Sleep Consortium, Slovak University of Technology, Smart Immune, SMS Pharmaceuticals, Society of NeuroInterventional Surgery, Society of Vascular and Interventional Neurology, Sohm, Soleno Therapeutics, Solid Biosciences, Soligenix, Soli Organic, Solve GNE, Sona Nanotech, Sonde Health, Sonrai Analytics, Sookmyung Women's University, SOPHiA Genetics, Soroka Medical Center, Sorrento Therapeutics, Southwest College of Naturopathic Medicine & Health Sciences, Southwest Transplant Alliance, Spacelabs Healthcare, Spanish Lung Cancer Group, Spanish National Cancer Research Centre, Spanish State Research Agency, Spark Biomedical, Spark Therapeutics, Sparrow Pharmaceuticals, Spectrum Health, Spectrum Solutions, Sphingotec, SpikImm, SpineThera, Spiral Therapeutics, SpliceBio, SpotitEarly, SpringWorks Therapeutics, SpyBiotech, SQI Diagnostics, SS Innovations International, St. Baldrick's Foundation, St. Jude Children's Research Hospital, St. Lukes Health System Clinically Integrated Providers, Stallergenes Greer, Stand Up To Cancer, Stanford University, Stanford University School of Medicine, StarkAge Therapeutics, Starpharma, Starzl Network for Excellence in Pediatric Transplantation, Statens Serum Institute, State University of New York, Stealth BioTherapeutics, Stella Diagnostics, Stellenbosch University, Stem of Hope, Steno Diabetes Center, SteroTherapeutics, Stevenson Memorial Hospital, St Michael's Hospital, Stoic Bio, Stoked Bio, Stony Brook University, Strata Oncology, StrideBio, Strides Arcolab, Structural Genomics Consortium, SUDA Pharmaceuticals, Summit Clinical Research, Sun Genomics, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Sun Pharma Global, Sunshine Biopharma, Sunshine Lake Pharma, Sunstone Therapies, SUNY Upstate Medical University, Suono Bio, Surge Cardiovascular, Susan G. Komen for the Cure, Swedish Research Council, Swinburne University, Swiss Institute of Bioinformatics (SIB), Swiss Integrative Center for Human Health, SymphonyAI, SynAct Pharma, Synaptogenix, Synbal, Syncell, Synchron, SynDevRx, Synertex, SynGAP Research Fund, Syngene, Syntegra, Synthekine, SyntheticMR, Syntropy, Sysmex, T-Cure Bioscience, T2 Biosystems, Tabula Rasa HealthCare, Tachyon Therapeutics, Tachyum, Taiho, Taiwan Precision Medicine Initiative, Takara Bio USA, Takeda Oncology, Takeda Pharmaceutical, Talus Bioscience, Tampa General Hospital Cancer Institute, Target ALS Foundation, Target RWE, Taysha Gene Therapies, TB Alliance, TC BioPharm, TeamConnor Childhood Cancer Foundation, Technology University Dresden, Tel Aviv Sourasky Medical Center, Tel Aviv University, Telix Pharmaceuticals, Telus Health, Tempest Therapeutics, Temple University, Tempus, Tenet Healthcare, Terasaki Institute for Biomedical Innovation, Terran Biosciences, TeselaGen, Tessa Therapeutics, Tessera Therapeutics, Tetherex Pharmaceuticals, Tetratherix, Teva Pharmaceutical Industries, Tevard Biosciences, Texas A&M Health Science Center, Texas A&M University, Texas Biomedical Research Institute, Texas Heart Institute, TFC Therapeutics, TGen Drug Development, Tharimmune, The Access to Advanced Health Insitute (AAHI), The Cure Parkinson's Trust, The Healthy Aging Company, The International AIDS Vaccine Initiative, The Jackson Laboratory, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theragnostics, Theralink Technologies, Therapeutic Solutions International, TheraPsil, Theratechnologies, Theriva Biologics, Thermo Fisher Scientific, Theryq, The Silverstein Foundation for Parkinson's, The Technical University Of Munich, ThinkCyte, ThinkGenetic, THINK Surgical, Thomas Jefferson University, Thomas Scientific, Three Lakes Foundation, Thylacine Biotherapeutics, Tiba Biotech, Tigerlily Foundation, Titan Pharmaceuticals, Tivic Health Systems, Tiziana Life Sciences, Tohoku University, Tokai University, Tokyo Institute of Technology, Tokyo Medical and Dental University, TONIX Pharmaceuticals, Torrent Pharmaceuticals, Tottori University, Totus Medicines, Touchlight, Toxys, Toyohashi University of Technology, Transcend Therapeutics, TransCode Therapeutics, Transgene, Translational Genomics Research Institute, TransMedics, Travera, Treadwell Therapeutics, Treatment.com International, TreeFrog Therapeutics, Trestle Biotherapeutics, Trethera, Trinity College Dublin, TriSalus Life Sciences, TruDiagnostic, Tryp Therapeutics, Tufts Medical Center, Tufts University, Tulane University, TumorGen, Turn Biotechnologies, Turner Imaging Systems, Turning Point Therapeutics, Turnstone Biologics, Twist Bioscience, Ubiquigent, Ubiquitome, U CAN-CER VIVE Foundation, UCB, UK Government, Ultivue, Ultragenyx Pharmaceuticals, UMass Chan Medical School, UMass Memorial Medical Center, Undisclosed Company, UniQuest, UNITAID, United BioPharma, UnitedHealthcare, United Nations Children Fund, Univeristy of Durham, Universe Pharmaceuticals, Universidad de los Andes, Universidade Estadual de Campinas, Universite Laval, University College Cork, University College London, University Gottingen, University Health Network, University Hospital Bonn, University Hospital Heidelberg, University Hospital Magdeburg, University Hospital of Leuven, University Hospitals Accountable Care Organization, University Hospitals Case Medical Center, University Hospitals Ventures, University Libre of Brussels, University Medical Center Utrecht, University of Aberdeen, University of Adelaide, University of Alabama, University of Alabama at Birmingham, University of Alberta, University of Amsterdam, University of Antwerp, University of Arizona, University of Arkansas, University of Auckland, University of Augsburg, University of Barcelona, University of Basel, University of Bath, University of Bern, University of Birmingham, University of Bonn, University of Bordeaux I, University of British Columbia, University of Calgary, University of California, University of California, Davis, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California Riverside, University of California San Francisco, University of California Santa Barbara, University of Cambridge, University of Catholic Sacro Cuore, University of Central Florida Research Foundation, University of Chicago, University of Cincinnati, University of Colorado, University of Connecticut, University of Copenhagen, University of Delaware, University of Dundee, University of East London, University of Edinburgh, University of Erlangen, University of Exeter, University of Florida, University of Freiburg, University of Geneva, University of Georgia, University of Glasgow, University of Granada, University of Health Sciences Antigua, University of Heidelberg, University of Helsinki, University of Hong Kong, University of Houston, University of Illinois, University of Illinois at Chicago, University of Illinois Urbana-Champaign, University of Insubria, University of Iowa, University of Jaen, University of Kansas, University of Kentucky, University of Lausanne, University of Leeds, University of Leipzig, University of Leuven, University of Liverpool, University of Ljubljana, University of Louisville, University of Manchester, University of Marburg, University of Maryland, University of Maryland, Baltimore County, University of Maryland Baltimore, University of Maryland School of Medicine, University of Massachusetts, University of Massachusetts Medical School, University of Memphis, University of Miami, University of Michigan, University of Milano-Bicocca, University of Minnesota, University of Mississippi, University of Missouri, University of Montreal, University of Nebraska, University of Newcastle, University of New Mexico, University of New South Wales, University of North Carolina, University of Notre of Dame, University of Oklahoma, University of Oslo, University of Ottowa, University of Oulu, University of Oxford, University of Pennsylvania, University of Pittsburg, University of Pittsburgh, University of Pittsburgh Medical Center, University of Quebec, University of Queensland, University of Rennes, University of Rochester, University of Rochester Medical Center, University of Rome, University of Sao Paulo, University of Saskatchewan, University of Sheffield, University of Southampton, University of South Australia, University of South Carolina, University of Southern California, University of Southern Denmark, University of South Florida, University of Strathclyde, University of Surrey, University of Sydney, University of Tennessee, University of Texas, University of Texas Health Science Center at Houston, University of Texas Health SCience Center at San Antonio, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of the Highlands and Islands, University of the Witwatersrand, University of Tokyo, University of Toronto, University of Tsukuba, University of Tubingen, University of Tulsa, University of Turin, University of Twente, University of Utah, University of Vermont, University of Verona, University of Virginia, University of Washington, University of Waterloo, University of Western Ontario, University of Wisconsin, University of Wisconsin-Madison, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wollongong, University of Zaragoza, University of Zurich, University Paris Diderot, Unravel Biosciences, Uppsala University, UroGen Pharma, Us2.ai, USANA Health Science, US Army Medical Research and Material Command, US Army Medical Research Institute of Chemical Defense, US Department of Agriculture, Usher III, Usher Syndrome Coalition, US Medical Innovations, US Oncology Research, UT Health Sciences Center, UT Southwestern Medical Center, Vaica Medical, Valence Discovery, Valent Biosciences, Vall d’Hebron Research Institute, Valo Health, Valo Therapeutics, Vanderbilt University, Vapotherm, Varian Medical Systems, Vaxalto Biotherapeutics, Vaxart, Vaxess Technologies, Vaxxas, Vaxxinity, VBI Vaccines, Vector BioMed, Vector BioPharma, Vector Institute, VectorY Therapeutics, Veeva Systems, Vela Diagnostics, Veltmeyer MD, Ventus Therapeutics, Veracyte, Verana Health, Veranome Biosystems, Vera Therapeutics, Verge Genomics, Verily, VerImmune, VeriSIM Life, Verismo Therapeutics, Veritas, Versiti Blood Research Institute, Vesigen Therapeutics, Vestibular Disorders Association, Viatris, VIB, Vibrent Health, Vicarious Surgical, Victoria University, ViewRay, ViiV Healthcare, Vilya, Vincere Biosciences, Vincere Cancer Center, Viome, Vir Biotechnology, Virginia Commonwealth University, Virginia Tech, Virginia Tech Carilion Research Institute, Virica Biotech, Virios Therapeutics, ViroCell Biologics, Virogen, Vision Institute, VisualDx, VitalHub, Vital Images, Vithas Group, Vivasc Therapeutics, Vivera Pharmaceuticals, Viz.ai, Vizient, Vocan Biotechnologies, Voltron Therapeutics, VoxNeuro, Voxtur, Vrije Universiteit Brussel, Vyriad, Wageningen University, Wake Forest Institute for Regenerative Medicine, Wake Forest University, Wake Forest University Baptist Medical Center, Walden Biosciences, Walter Reed Army Institute of Research, Wanda Fish Technologies, Waseda University, Washington University in St Louis, Waters Corporation, WAVE Life Sciences, WCG Trifecta, Weill Cornell Medical College, Weizmann Institute, Wellcome Trust, Wellcome Trust Sanger Institute, Wellmarker Bio, Wesana Health, Westchester Medical Center Health Network, Western New England University, Western University, West German Study Group, Whitehead Institute, WhiteLab Genomics, Whitman-Walker Institute, William Harvey Research Instutute, Wilmot Cancer Institute, WIN Consortium, Windber Research Institute, Windtree Therapeutics, Winnipeg Regional Health Authority, Wisconsin Alumni Research Foundation, Wisconsin Health Information Organization, Wistar Institute, Wolverine Foundation, Wonkwang University, Worldwide Clinical Trials, WUGEN, Wylder Nation Foundation, Wyss Center, Wyss Institute, Xanadu Bio, Xavier University of Louisiana, XBiotech, Xcellomics, Xencor, Xenetic Biosciences, Xenon Pharmaceuticals, XenoTherapeutics, Xentria, Xilis, XNK Therapeutics, Xylyx Bio, Y2X Life Sciences, Yale Cancer Center, Yale School of Medicine, Yale University, Yeda Research and Development Company, Yesse Technologies, Yield10 Bioscience, Yingli Pharma, Yissum Research Development, Ymmunobio, Yonsei University Severance Hospital, Young Blood Institute, Yumanity Therapeutics, Zalgen Labs, ZAP Surgical Systems, ZebiAI Therapeutics, Zef Scientific, Zelluna Immunotherapy, Zeta Surgical, Zeteo Tech, Zevra Therapeutics, Zhejiang Jiuzhou Pharmaceutical, Ziphius Vaccines, Zogenix, Zura Bio, ZyVersa Therapeutics, Zywie, ZZ Biotech

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!